Your browser doesn't support javascript.
loading
NF-κB Activator 1 downregulation in macrophages activates STAT3 to promote adenoma-adenocarcinoma transition and immunosuppression in colorectal cancer.
Wang, Shunyi; Kuai, Yihe; Lin, Simin; Li, Li; Gu, Quliang; Zhang, Xiaohan; Li, Xiaoming; He, Yajun; Chen, Sishuo; Xia, Xiaoru; Ruan, Zhang; Lin, Caixia; Ding, Yi; Zhang, Qianqian; Qi, Cuiling; Li, Jiangchao; He, Xiaodong; Pathak, Janak L; Zhou, Weijie; Liu, Side; Wang, Lijing; Zheng, Lingyun.
Afiliación
  • Wang S; School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, 510006, Guangdong, P. R. China.
  • Kuai Y; School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, 510006, Guangdong, P. R. China.
  • Lin S; Department of Gastroenterology, Guangdong Provincial Key Laboratory of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
  • Li L; School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, 510006, Guangdong, P. R. China.
  • Gu Q; School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, 510006, Guangdong, P. R. China.
  • Zhang X; Hospital of Guangdong Provincial Hospital of Traditional Chinese Medicine, Zhuhai, 519015, China.
  • Li X; Department of Pathology, People's Hospital of Shenzhen Bao an District, Shenzhen, 518101, China.
  • He Y; Department of Pathology, People's Hospital of Shenzhen Bao an District, Shenzhen, 518101, China.
  • Chen S; School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, 510006, Guangdong, P. R. China.
  • Xia X; School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, 510006, Guangdong, P. R. China.
  • Ruan Z; School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, 510006, Guangdong, P. R. China.
  • Lin C; School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, 510006, Guangdong, P. R. China.
  • Ding Y; School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, 510006, Guangdong, P. R. China.
  • Zhang Q; School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, 510006, Guangdong, P. R. China.
  • Qi C; School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, 510006, Guangdong, P. R. China.
  • Li J; School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, 510006, Guangdong, P. R. China.
  • He X; School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, 510006, Guangdong, P. R. China.
  • Pathak JL; Guangdong Engineering Research Center of Oral Restoration and Reconstruction, Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Affiliated Stomatology Hospital of Guangzhou Medical University, Guangdong, 510182, Guangzhou, China.
  • Zhou W; Department of General Surgery & Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, First Clinical Medical School, Southern Medical University, Guangzhou, 510515, P. R. China.
  • Liu S; Department of Gastroenterology, Guangdong Provincial Key Laboratory of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China. sideliu@smu.edu.cn.
  • Wang L; School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, 510006, Guangdong, P. R. China. wanglijing62@163.com.
  • Zheng L; School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, 510006, Guangdong, P. R. China. zhenglingyun@gdpu.edu.cn.
BMC Med ; 21(1): 115, 2023 03 29.
Article en En | MEDLINE | ID: mdl-36978108

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Adenocarcinoma / Adenoma Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: BMC Med Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Adenocarcinoma / Adenoma Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: BMC Med Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article
...